Dashboard
Manage Tickers

ALVOAlvotech

Nasdaq alvotech.com


$ 14.52 $ 0.03 (0.21 %)    

Thursday, 02-May-2024 15:50:43 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 429.07 $ 5.38 (1.28 %)
DIA $ 382.31 $ 3.34 (0.88 %)
SPY $ 505.01 $ 4.68 (0.94 %)
TLT $ 88.87 $ 0.38 (0.43 %)
GLD $ 213.12 $ -0.66 (-0.31 %)
$ 14.51
$ 14.47
$ 0.00 x 0
$ 0.00 x 0
$ 14.46 - $ 14.55
$ 6.70 - $ 18.00
231,629
na
3.87B
$ 0.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

alvotech-announced-positive-topline-results-from-a-confirmatory-clinical-study-for-avt05-alvotechs-proposed-biosimilar-to-simponi-and-simponi-aria-golimumab
Alvotech Announced Positive Topline Result...
04/24/2024 08:02:35

fifth-third-bancorp-reports-upbeat-earnings-joins-metropolitan-bank-holding-paramount-global-and-other-big-stocks-moving-higher-on-friday
Fifth Third Bancorp Reports Upbeat Earning...
04/19/2024 14:40:21

Core News & Articles
Alvotech Inks Long-Term Agreement With A S...
04/19/2024 10:11:54

"This new partnership agreement supports our financial guidance and reflects Alvotech's strong commitment to increasing...

Core News & Articles
Alvotech, Teva Announce US FDA Approval Of...
04/16/2024 21:33:05

Under the strategic partnership between Teva and Alvotech, Teva is responsible for the exclusive commercialization of SELARSDI ...

alvotech-receives-fda-approval-for-selarsdi-for-moderate-to-severe-plaque-psoriasis
Alvotech Receives FDA Approval For Selarsd...
04/16/2024 19:46:42

Alvotech receives FDA approval for Selarsdi for moderate to severe plaque psoriasisAdult patients with:moderate to severe plaqu...

aehr-test-systems-reports-preliminary-results-joins-dyne-therapeutics-united-airlines-and-other-big-stocks-moving-lower-on-monday
Aehr Test Systems Reports Preliminary Resu...
03/25/2024 14:32:02

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday.

alvotech-announces-increased-the-companys-share-capital-by-an-amount-of-130k-by-issuing-13m-ordinary-shares
Alvotech Announces Increased The Company's...
03/22/2024 20:24:51

Alvotech (NASDAQ:ALVO) (the "Company"), a global biotech company specializing in the development and manufacture of bio...

barclays-maintains-overweight-on-alvotech-raises-price-target-to-20
Barclays Maintains Overweight on Alvotech,...
03/22/2024 10:42:15

Barclays analyst Balaji Prasad maintains Alvotech (NASDAQ:ALVO) with a Overweight and raises the price target from $17 to $20.

alvotech-fy-2023-gaap-eps-243-misses-107-estimate-sales-93400m-miss-112470m-estimate
Alvotech FY 2023 GAAP EPS $(2.43) Misses $...
03/20/2024 20:18:38

Alvotech (NASDAQ:ALVO) reported quarterly losses of $(2.43) per share which missed the analyst consensus estimate of $(1.07) by...

earnings-scheduled-for-march-20-2024
Earnings Scheduled For March 20, 2024
03/20/2024 09:32:15

Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per s...

alvotechs-earnings-a-preview
Alvotech's Earnings: A Preview
03/19/2024 14:01:07

why-is-generic-drugs-player-teva-pharma-stock-trading-higher-today
Why Is Generic Drugs Player Teva Pharma St...
02/26/2024 13:48:24

FDA-approved Simlandi (adalimumab-ryvk): a high-concentration biosimilar to Humira for rheumatoid arthritis, psoriasis, and more.

Core News & Articles
Late Friday, Alvotech And Teva Pharmaceuti...
02/26/2024 12:22:42

alvotech-has-accepted-an-offer-from-investors-for-the-sale-of-1013m-shares-for-approximately-166m-at-1641share-or-isk-2250share-the-transaction-will-be-made-on-the-nasdaq-iceland-exchange
Alvotech Has Accepted An Offer From Invest...
02/26/2024 09:31:27

Core News & Articles
Alvotech Has Settled With Johnson & Johnso...
02/15/2024 11:38:14

Regulatory approval for AVT04 in these markets has already been granted. Market applications for AVT04 are currently pending in...

american-airlines-to-rally-around-32-here-are-10-top-analyst-forecasts-for-monday
American Airlines To Rally Around 32%? Her...
01/29/2024 12:34:22

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

barclays-upgrades-alvotech-to-overweight-raises-price-target-to-17
Barclays Upgrades Alvotech to Overweight, ...
01/29/2024 10:21:01

Barclays analyst Balaji Prasad upgrades Alvotech (NASDAQ:ALVO) from Equal-Weight to Overweight and raises the price target f...

alvotech-announces-top-line-results-from-a-pharmacokinetic-study-for-avt03-a-proposed-biosimilar-for-prolia-and-xgeva
Alvotech Announces Top-Line Results from a...
01/29/2024 09:02:25

Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for pa...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
01/19/2024 17:31:10

alvotech-provides-update-on-status-of-biologics-license-applications-for-avt02-and-avt04
Alvotech Provides Update On Status Of Biol...
01/19/2024 16:31:55

Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for pa...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION